Results for tag: "Pediatric Brain Tumor Drug"

The Pediatric Brain Tumor Drug market is a subset of the larger Brain Cancer Drugs market. It focuses on drugs specifically designed to treat brain tumors in children. These drugs are typically used to reduce the size of the tumor, reduce symptoms, and improve quality of life. They may also be used to prevent the tumor from growing or spreading. Common drugs used in this market include temozolomide, vincristine, and carboplatin. The Pediatric Brain Tumor Drug market is highly competitive, with many companies offering treatments. Some of the major players in this market include Novartis, Pfizer, Merck, and Roche. Other companies include Bristol-Myers Squibb, AstraZeneca, and Eli Lilly. Show Less Read more